Countries citing scholars working at Institute for Clinical Pharmacodynamics (United States)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Institute for Clinical Pharmacodynamics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Institute for Clinical Pharmacodynamics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Institute for Clinical Pharmacodynamics (United States) more than expected).
Fields of papers published by authors at Institute for Clinical Pharmacodynamics (United States)
This network shows the impact of papers affiliated with Institute for Clinical Pharmacodynamics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Institute for Clinical Pharmacodynamics (United States) at the time of their publication.
About Institute for Clinical Pharmacodynamics (United States)
In recent decades, authors affiliated with Institute for Clinical Pharmacodynamics (United States) have published 293 papers, which have received a total of 9.3k indexed citations . Scholars at this organization have produced 98 papers in Molecular Medicine, 27 papers in Applied Microbiology and Biotechnology, 165 papers in Pharmacology, 24 papers in Clinical Biochemistry and 53 papers in Infectious Diseases on the topics of Antibiotics Pharmacokinetics and Efficacy (159 papers), Antibiotic Resistance in Bacteria (98 papers), Pneumonia and Respiratory Infections (64 papers), Antibiotic Use and Resistance (27 papers), Bacterial Identification and Susceptibility Testing (24 papers), Antimicrobial Resistance in Staphylococcus (23 papers), Antifungal resistance and susceptibility (23 papers) and Pharmaceutical studies and practices (11 papers). Their work is cited by papers focused on Molecular Medicine (2.7k citations), Applied Microbiology and Biotechnology (731 citations), Pharmacology (3.7k citations), Infectious Diseases (2.7k citations) and Clinical Biochemistry (755 citations). Authors at Institute for Clinical Pharmacodynamics (United States) collaborate with scholars in United States, United Kingdom and Australia and have published in prestigious journals including Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases and The Journal of Clinical Pharmacology. Some of Institute for Clinical Pharmacodynamics (United States)'s most productive authors include Paul J. Ambrose, Sujata M. Bhavnani, George L. Drusano, Christopher M. Rubino, Alan Forrest, Arnold Louie, David R. Andes, Tawanda Gumbo, Evelyn J. Ellis‐Grosse and Reuben Ramphal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact